Blood clotting is a complex physiological process essential for preventing excessive bleeding following vascular injury. Platelets, the anucleate cell fragments circulating in the bloodstream, play a critical role by rapidly aggregating at damaged vascular sites to form a physical barrier. Central to this process is the platelet cytoskeleton, an internal framework of protein fibers whose dynamic remodeling is driven by the motor activity of myosin molecules. However, prior to this research, the precise molecular mechanism by which platelet myosin remains quiescent until its activation was not well understood.

Utilizing the extraordinary resolving power of cryo-EM technology housed within the University of Leeds’ Astbury Biostructure Laboratory, the team generated high-resolution three-dimensional images of human nonmuscle myosin 2A, the specific isoform present in platelets. These structures revealed that platelet myosin adopts a folded “shutdown” conformation, whereby critical regions of the motor protein engage in intramolecular interactions that inhibit its ATPase activity, effectively locking the molecule in an inactive state. This conformational folding is key to preventing premature contraction within platelets and ensuring clotting only occurs when physiologically necessary.

One of the most impactful aspects of these structural findings is the identification of molecular “hotspots” for inherited mutations within these critical regulatory regions of myosin. These mutation sites, some of which are implicated in bleeding disorders, can destabilize the shutdown fold, leading to aberrant, premature activation of platelet myosin. This dysregulation impairs the proper assembly of the platelet cytoskeleton and compromises the mechanical forces required to consolidate a stable clot, thus elucidating a direct molecular basis for certain hemorrhagic conditions.

The study’s in-depth structural characterization also underscores how these platelet myosins differ from their muscle counterparts. Unlike the myosins responsible for muscle contraction, platelet myosin operates within non-muscle cells and is tailored for rapid remodeling of the cellular architecture in response to injury signals. This specialization highlights the exquisite evolutionary adaptation of myosin isoforms to fulfill diverse cellular roles, from cardiac and skeletal muscle contraction to blood clot stabilization.

Moreover, the investigation extends beyond hematology, as mutations in the same myosin isoform have also been implicated in kidney diseases and hereditary forms of deafness, emphasizing the widespread physiological importance of tightly controlled myosin activity. The structural elucidation of the shutdown mechanism thus has broad biomedical implications, potentially informing therapeutic approaches across multiple disorders involving myosin malfunction.

Professor Michelle Peckham, lead investigator and expert in molecular cell biology, emphasized the transformative impact of these findings, stating, “Understanding how platelet myosin is normally suppressed provides a framework for interpreting how genetic mutations can tip the balance toward disease states by promoting uncontrolled motor activity.” Such mechanistic insight opens new avenues for the development of drugs designed to stabilize the inactive form of myosin or correct the effects of pathogenic mutations.

Glenn Carrington, postdoctoral researcher contributing to the project, highlighted the sophistication of the switch-like behavior of platelet myosin: “The ability to visualize, at atomic scale, how a simple chemical modification can flip the protein from its inactive ‘shutdown’ configuration into an active motor explains a crucial regulatory principle underlying blood clot initiation.” This precise molecular switch ensures that platelet contraction is tightly regulated both spatially and temporally during the clotting cascade.

The multidisciplinary approach taken by the Astbury Centre for Structural Molecular Biology team combined structural biology, genetics, and biochemistry to build a holistic picture of platelet myosin regulation. This integrative strategy strengthens the conclusions, demonstrating how structural destabilization leads to functional consequences, such as defective clot architecture and impaired wound healing. Such comprehensive knowledge is crucial for translating basic science discoveries into clinical solutions.

This research represents a paradigm shift in our understanding of blood coagulation, moving from descriptive models to detailed molecular mechanisms. It solidifies the role of cryo-EM as an indispensable tool in structural molecular biology, capable of unraveling the dynamic conformations that govern protein function within human health and disease. Additionally, by mapping mutation hotspots, the study provides a genetic blueprint for diagnosing and potentially targeting inherited bleeding disorders with precision medicine approaches.

Ultimately, detailing the shutdown conformation of platelet myosin sets a new foundation for exploring therapeutic interventions aimed at modulating clot formation. For patients suffering from bleeding disorders due to defective myosin regulation, these findings signal hope for future treatments that restore normal platelet function. As blood clotting is fundamental to survival, the ripple effects of understanding its molecular regulation will extend well beyond hematology, influencing broader areas of medicine and biology.

Subject of Research: Cells

Article Title: Cryo-EM structure of shutdown human nonmuscle myosin 2A

News Publication Date: 17-Apr-2026

Web References:
Science Advances article

References:
Peckham M, Carrington G, et al. Cryo-EM structure of shutdown human nonmuscle myosin 2A. Science Advances. 2026; DOI: 10.1126/sciadv.aed1858.

Keywords
Myosins, Blood coagulation, Cryo electron microscopy, Proteins, Hematology, Structural biology, Motor proteins, Platelet function, Genetic mutations, Bleeding disorders, Cytoskeleton, Molecular mechanism

RNA polymerase II is a molecular machine fundamental to gene expression. It orchestrates the synthesis of messenger RNA by reading the DNA template, marking the first crucial step in translating genetic information into proteins and other functional molecules. While the primary architecture and major components of the enzyme have been studied extensively, the exact molecular choreography of its biochemical interactions, especially the involvement of solvents like water, remained elusive until this new research venture. The utilization of advanced cryo-EM has now provided multiple high-resolution snapshots of RNA polymerase II in the act of transcription, illuminating the microscopic actors behind this essential biological function.

The study meticulously cataloged hundreds to over a thousand discrete water molecules positioned in close proximity to the enzyme, many of which were strategically located at critical catalytic and recognition sites within the transcription complex. These waters form elaborate hydrogen-bond networks bridging RNA polymerase II, DNA strands, and incoming ribonucleotide substrates, suggesting their integral involvement in maintaining structural stability and mediating critical chemistry. This nuanced interaction expands our understanding of the molecular environment governing gene transcription, revealing that water’s role transcends simple solvation to actively facilitate enzymatic function.

One of the most striking new conceptual advancements is the active participation of water molecules in proton transfer—a vital chemical step in polymerase catalysis. Proton transfer is central to the addition of nucleotide units to the growing RNA chain, enabling the formation of phosphodiester bonds that link ribonucleotides. Water molecules act as proton donors or acceptors, establishing transient pathways through which protons are effectively shuttled. This intricate mechanism is essential to enzymatic efficiency and fidelity, underscoring water’s critical chemical role beyond mere hydration or passive involvement.

Moreover, water’s involvement extends to substrate recognition, where it helps the polymerase distinguish the correct ribonucleotide triphosphates from incorrect analogs. Through enabling specific hydrogen bonding and stabilizing conformations conducive to selective binding, water molecules enhance the enzyme’s accuracy in transcription. This function highlights a sophisticated “molecular proofreading” aspect facilitated by aqueous solvent networks, which contributes to the high fidelity of gene expression fundamental to cellular function and organismal health.

As investigations progressed, researchers noted that these water molecule arrangements are remarkably conserved through evolutionary lineages—from bacterial RNA polymerases to those found in yeast, and potentially to humans as well. This evolutionary conservation signals the fundamental importance of water-mediated mechanisms within basal transcription machinery across life forms. This paradigm challenges the traditional protein-centric views of gene expression machinery and calls for an expanded framework that includes solvent dynamics as an integral component of enzymatic function and regulation.

Beyond their chemical roles, water molecules serve a structural purpose by stabilizing key enzyme conformations during the transcription cycle. By reinforcing hydrogen bond networks and bridging functional groups within the protein, DNA, and RNA substrates, waters help maintain the architectural integrity of the active site. This structural stabilization likely contributes to the enzyme’s resilience under diverse cellular conditions, ensuring consistent transcription efficiency and adaptability.

The technological breakthrough that facilitated these discoveries was the use of ultra-high-resolution cryo-electron microscopy, a method that has revolutionized molecular biology by allowing direct visualization of biomolecules at near-atomic resolution. This approach provided unprecedented clarity, revealing subtle solvent interactions that had previously escaped detection due to technical limitations of traditional structural biology methods such as X-ray crystallography or nuclear magnetic resonance. Cryo-EM thus opens new frontiers in decoding intricate molecular mechanisms with direct observations of water molecules in situ.

The implications of this discovery are manifold, extending from fundamental biology to applied biomedical sciences. Understanding the molecular role of water in transcription may guide the development of new drugs targeting RNA polymerase II, potentially disrupting pathogenic gene expression or fine-tuning genetic regulation in disease contexts. Since transcriptional dysregulation is implicated in numerous disorders, including cancers and genetic diseases, these insights provide a novel chemical and structural blueprint for therapeutic innovation.

Importantly, this research invites a re-evaluation of solvent contributions in enzymatic catalysis more broadly. Water molecules, traditionally viewed simply as a background solvent, can now be appreciated as dynamic, purposeful participants orchestrating complex biochemical reactions. This marks a conceptual shift in enzymology and molecular biology, elevating the role of solvents from passive milieu components to active molecular agents essential for life’s chemistry.

The study was led by Dr. Dong Wang, a professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. Published on April 30, 2026, in the journal Molecular Cell, the research integrates cutting-edge microscopy, biochemical precision, and evolutionary biology to redefine our understanding of the gene transcription process at the molecular level.

As science continues to peel back layers of complexity in the cell’s machinery, this work exemplifies how advances in technology can illuminate previously invisible dimensions of biological function. The discovery that water molecules are integral components of RNA polymerase II activity has the power to transform molecular genetics, pharmacology, and our very conception of the biochemical foundations of life.

Subject of Research: The role of water molecules in facilitating the enzymatic mechanism of RNA polymerase II during gene transcription.

Article Title: (Not explicitly provided in the content)

News Publication Date: April 30, 2026

Web References:

• Dong Wang Profile – UC San Diego Skaggs School of Pharmacy
• Original Research Article – Molecular Cell

Image Credits: Credit: Dong Wang

Keywords

DNA, RNA, Gene transcription, RNA polymerase II, Water molecules, Proton transfer, Cryo-electron microscopy, Molecular biology, Genetic expression, Enzymatic catalysis, Evolutionary conservation, Molecular genetics

Multiple myeloma, characterized by malignant proliferation of monoclonal plasma cells, frequently leads to the overproduction of immunoglobulin light chains. These light chains can misfold and aggregate, depositing as amyloid fibrils in various tissues—a pathological hallmark linked to organ dysfunction and poor prognosis. Despite decades of study, the precise molecular organization of amyloid fibrils derived from patient tissues remained elusive, confounding efforts to devise targeted therapies. This new study addresses that knowledge gap by harnessing state-of-the-art cryo-EM techniques to capture high-resolution structural snapshots of native light chain fibrils.

The research team meticulously isolated fibrils from the abdominal fat tissue, a minimally invasive biopsy site commonly utilized in amyloid detection, ensuring pathological relevance of the specimens studied. Using advanced cryo-EM imaging and reconstruction protocols, they resolved the fibril ultrastructure at near-atomic resolution, illuminating the conformational motifs responsible for light chain polymerization. This approach bypasses the limitations of recombinant fibrils formed in vitro, which often fail to recapitulate the complex heterogeneity observed in patient-derived amyloids.

Structurally, the light chain fibrils showcased a distinctive cross-β architecture—a hallmark of amyloids—composed of stacked β-strands oriented perpendicular to the fibril axis. The spatial arrangement revealed polymorphic variations reflecting distinct patient-specific light chain sequences, which influence the propensity for fibril assembly and tissue tropism. Key hydrophobic and charged residues were found to mediate interstrand stabilization via hydrogen bonding and salt bridges, providing a molecular rationale for amyloid stability and insidious persistence in vivo.

One of the most striking findings was the elucidation of “steric zipper” interfaces—precisely interdigitated side chains from adjacent β-sheets forming a dry, tightly packed core. These zipper-like contacts confer remarkable insolubility and resistance to proteolytic degradation, challenging conventional therapeutic modalities. Understanding the nature of these interfaces offers new avenues for designing small molecules or antibodies capable of disrupting fibril integrity by targeting these critical contact points.

Moreover, the cryo-EM maps enabled visualization of variable domain conformations within the fibrils, clarifying how patient-specific amino acid substitutions modify fibrillar morphology. These insights explain divergent clinical manifestations and progression rates among multiple myeloma patients afflicted with amyloidosis, highlighting the importance of precision medicine approaches tailored to fibril structure and sequence.

This research also unearthed evidence of post-translational modifications such as glycosylation and oxidation within the fibrillar proteins, factors hypothesized to promote aggregation kinetics or fibril stability. Capturing these modifications in situ enhances understanding of the pathological environment influencing amyloidogenesis and informs development of intervention strategies that can disrupt these biochemical processes.

Importantly, the direct extraction and imaging of fibrils from patient tissues circumvent artifact generation inherent in overexpression or synthetic fibril models. This establishes a new standard for structural amyloid biology, anchoring future studies in patient-relevant molecular conformations. The methodology demonstrates how advanced imaging synergized with clinical sampling can overcome limitations that historically impeded mechanistic insights in amyloid diseases.

By elucidating the atomic-level structure of light chain amyloid fibrils formed in vivo, this work bridges structural biology with clinical pathology and therapeutics. The detailed knowledge of fibril architecture paves the way for rational drug design targeting amyloid disruption or prevention. Potential strategies include molecules capable of capping growing fibril ends, destabilizing steric zippers, or inhibiting nucleation stages critical for fibril genesis.

Furthermore, understanding fibril polymorphism informs biomarker development to improve diagnosis and monitor therapeutic efficacy in multiple myeloma-associated amyloidosis. Structural signatures derived from cryo-EM data may enable imaging agent design or serum assays that detect specific fibril conformers correlating with patient prognosis or treatment response.

The implications extend beyond multiple myeloma since light chain amyloidosis shares pathological mechanisms with a spectrum of degenerative diseases involving amyloid fibril deposition. Comparative analyses enabled by this study’s cryo-EM maps can elucidate convergent and divergent principles of amyloid formation across protein families, enriching our general understanding of protein misfolding diseases.

This milestone exemplifies how technological breakthroughs in cryo-EM, coupled with sophisticated biochemical isolation from patient specimens, are revolutionizing structural medicine. As cryo-EM accessibility expands, applying similar workflows to other clinical amyloid presentations promises rapid advancement of personalized therapeutics targeting the root molecular causes.

In conclusion, through meticulous cryo-EM characterization of native light chain fibrils derived from multiple myeloma patients’ abdominal fat biopsies, scientists have charted uncharted molecular terrain that will undeniably influence both basic amyloid science and clinical management strategies. This fusion of structural detail with patient-specific pathology heralds a new era in conquering devastating amyloid diseases by illuminating precise molecular targets for future medicines.

Subject of Research: Cryo-electron microscopy structural analysis of light chain amyloid fibrils isolated from abdominal fat biopsies in multiple myeloma patients.

Article Title: Cryo-EM structures of light chain fibrils from abdominal fat biopsies of multiple myeloma patients.

Article References:
Yao, Y., Yao, S., Xu, Y. et al. Cryo-EM structures of light chain fibrils from abdominal fat biopsies of multiple myeloma patients. Nat Commun (2026). https://doi.org/10.1038/s41467-026-69784-4

Image Credits: AI Generated

HSV-1 is an enveloped virus responsible for a range of diseases, from oral cold sores to potentially life-threatening encephalitis, affecting millions globally. Central to the virus’s ability to infect host cells is gB, a highly conserved viral fusion protein that orchestrates the merger of the viral envelope with host cell membranes, a prerequisite for viral entry. Despite its critical role, the prefusion conformation of gB has long evaded structural characterization, limiting scientists’ capacity to fully understand its function and immune interaction dynamics.

In this seminal investigation, the research team employed advanced cryo-electron microscopy (cryo-EM) techniques to capture and reconstruct the elusive prefusion state of HSV-1 gB at near-atomic resolution. This approach enabled them to visualize the spatial arrangement of gB’s domains sharply before the protein undergoes the dramatic conformational changes necessary for membrane fusion. Previous studies had predominantly characterized postfusion structures, which represent the protein after its functional role in membrane merger, thus missing the critical initial conformational landscape.

Detailed structural analysis revealed that gB adopts a highly metastable configuration in its prefusion form, stabilized by a complex network of intramolecular interactions. Notably, the fusion loops, known for inserting into host membranes during the fusion process, are sequestered in a way that prevents premature exposure, underscoring a finely tuned mechanism of activation. This conformation likely represents a vulnerable window during which neutralizing antibodies can bind and block the fusion event, a potential Achilles’ heel for the virus.

Accompanying their structural insights, the researchers also explored how HSV-1 gB subverts the host immune response. Glycoprotein B is known to be a major target for neutralizing antibodies, yet HSV-1 deftly evades neutralization, allowing persistent infections and periodic reactivation. The study uncovered that gB’s prefusion form exhibits glycan shields and conformational masking that obscure critical epitopes from immune surveillance. This strategic cloaking likely limits the efficacy of antibody binding during natural infection and highlights the challenges in eliciting protective immunity via traditional vaccine approaches.

In addition to structural characterization, the study dissected the binding properties of several potent neutralizing antibodies isolated from infected individuals. These antibodies were found to preferentially recognize and stabilize the prefusion conformation of gB, effectively locking it in a non-functional state and preventing membrane fusion. Such detailed understanding of antibody binding modes provides valuable clues for the design of immunogens capable of eliciting similarly protective responses.

Crucially, the findings have broad implications for antiviral drug development. By defining the molecular landscape of prefusion gB, the team has identified potential small-molecule binding pockets and allosteric sites that could be exploited to design fusion inhibitors. These novel antiviral agents would act by stabilizing gB in its prefusion state or by disrupting the finely balanced conformational shifts necessary for fusion, cutting off the virus at its point of entry.

From a vaccine perspective, the study lays the foundation for next-generation HSV-1 vaccines that focus on presenting the prefusion form of gB as an immunogen. Traditional HSV vaccines have struggled partly due to the dynamic nature of gB and the predominance of postfusion epitopes, which are less effective in eliciting neutralizing antibodies. Stabilizing and displaying the prefusion gB trimer could focus immune responses on functionally relevant and vulnerable sites, enhancing vaccine efficacy and durability.

Moreover, this research sheds light on the evolutionary arms race between HSV-1 and the human immune system. The elegant structural mechanisms of immune evasion documented here reflect sophisticated viral adaptation, highlighting the challenges of mounting an effective immune defense against herpesviruses. Understanding these sophisticated escape strategies also informs broader virology, as similar principles may apply to other class III fusion proteins found across diverse viral families.

The methodology used in this study is a striking example of how integrated structural biology techniques, including cryo-EM, X-ray crystallography, and computational modeling, can be leveraged to tackle previously intractable viral proteins. By synergistically combining these approaches, the authors provided not only static structural data but also dynamic insights into the conformational flexibility and activation pathways of gB, enriching the functional narrative.

Equally important, the study establishes a framework to investigate glycoprotein B homologs in related herpesviruses, such as HSV-2, varicella-zoster virus, and cytomegalovirus. Given the conserved nature of this fusion machinery, the insights gained here could accelerate cross-species antiviral strategies and foster a unified approach to combat herpesvirus infections more broadly.

The intricate dance between viral glycoproteins and host cell membranes is fundamental to viral infectivity, and this study advances our grasp on one of nature’s most complex fusion machineries. By elucidating the prefusion structure and immune evasion tactics of HSV-1 gB, this work marks a transformative leap toward therapeutic innovations that could significantly reduce the global burden of herpes simplex virus infections.

In conclusion, this landmark investigation by Roark, Schaub, Shi, and colleagues propels our understanding of HSV-1 biology into an unprecedented molecular realm. By revealing the architecture of gB before membrane fusion, decoding the immune evasion landscape, and mapping neutralization vulnerabilities, they unlock a new frontier in herpesvirus research. The translational potential of these findings for antiviral drugs and vaccines promises to energize the field and offers hope for more effective interventions against this pervasive pathogen.

Subject of Research: Structural characterization, immune evasion, and neutralization mechanisms of herpes simplex virus 1 glycoprotein B (HSV-1 gB).

Article Title: Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B.

Article References:
Roark, R.S., Schaub, A.J., Shi, W. et al. Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B. Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02153-x

Image Credits: AI Generated